The Union Health and Family Welfare Minister launched the second phase of ‘Thalassemia Bal Sewa Yojna’ for the patients of the underprivileged society suffering from Thalassemia disease.
Second Phase of ‘Thalassemia Bal Sewa Yojna’
Key Points:Thalassemia Bal Sewa Yojna
- Thalassemia Bal Seva Yojana was launched in the year 2017.
- This is the Hematopoietic Stem Cell Transplantation (HSCT) program funded by Coal India under the ‘Corporate Social Responsibility-CSR’.
Hematopoietic stem cell transplantation (HSCT):
- HSCT is the transplantation of ‘Multipotent Hematopoietic Stem Cells’, usually derived from bone marrow, peripheral blood or umbilical cord blood.
- It is used [Autologous] ie the patient’s own stem cells], [Allogeneic stem cells are provided by one donor], Syngeneic [stemming] identical stem cells by an identical twin donor. Are provided] may be.
- The purpose of this program is to provide an opportunity to the families deprived of the treatment of Haemoglobinopathies like Thalassemia and Sickle Cell.
- The goal of this initiative was to provide financial assistance to a total of 200 patients which would not exceed Rs 10 lakh per HSCT.
- Statistics on prevalence of hidden carriers of various hemoglobinopathy diseases in India suggest that it is 2.9–4.6% for beta-thalassemia, while it may be up to 40% for sickle cell anemia among tribal populations.
- From the year 2020, the scheme has been expanded to include a total of 200 patients with aplastic anemia.